Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 1;35(10):1605-1614.
doi: 10.1097/QAD.0000000000002922.

Risk for incident diabetes is greater in prediabetic men with HIV than without HIV

Affiliations

Risk for incident diabetes is greater in prediabetic men with HIV than without HIV

Laurence Slama et al. AIDS. .

Abstract

Background: Diabetes mellitus is a major comorbidity in people with HIV (PWH). Hyperglycemia below diabetic range defines prediabetes (prediabetes mellitus). We compared the progression from prediabetes mellitus to diabetes mellitus in PWH and people without HIV (PWOH).

Methods: Fasting glucose was measured semiannually in the MACS since 1999. Men with prediabetes mellitus (fasting glucose between 100 and 125 mg/dl, confirmed within a year by fasting glucose in the prediabetes mellitus range or HbA1c between 5.7 and 6.4%) were included. The first visit with prediabetes mellitus was the baseline visit. Incident diabetes mellitus was defined as fasting glucose at least 126 mg/dl, confirmed at a subsequent visit, or self-reported diabetes mellitus, or use of anti-diabetes mellitus medication. We used binomial transition models to compare the progression from prediabetes mellitus to diabetes mellitus by HIV serostatus, adjusted for age, number of previous prediabetes mellitus to diabetes mellitus transitions, ethnicity, BMI, family history of diabetes mellitus, and hepatitis C virus (HCV) infection.

Results: Between 1999 and 2019, 1584 men (793 PWH; 791 PWOH) with prediabetes mellitus were included. At baseline, PWH were younger (48 vs. 51 years, P < 0.01), had lower BMI (26 vs. 27), were more frequently nonwhite (47 vs. 30%), and HCV-infected as per last measure (8 vs. 4%) than PWOH (all P < 0.01). Over a median 12-year follow-up, 23% of participants developed diabetes mellitus. In adjusted analyses, the risk for incident diabetes mellitus was 40% (95% CI: 0--80%) higher among PWH than PWOH (P = 0.04).

Conclusion: Among men with prediabetes mellitus, PWH had an increased risk of incident diabetes mellitus adjusted for competing risk factors, warranting the evaluation of diabetes mellitus prevention strategies.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

LS has served as a consultant to Gilead Sciences, Merck, ViiV. TTB has served as a consultant to ViiV Healthcare, Gilead Sciences, Merck, Theratechnologies, and Janssen. FJP has served on Advisory Boards and has done speaker programs for Gilead Sciences, Janssen, ViiV, Merck. JL has served as a consultant for Merck and Theratechnologies. JPV, JEL, AGA and BWB declared no conflict of interest.

Figures

Figure 1a.
Figure 1a.
Difference in the probability of transitioning from pre-DM to DM between PWH and PWOH at each year in time since the first visit with confirmed pre-DM. Estimates adjusted for age, number of previous transitions from pre-DM to DM, race/ethnicity, HCV infection as per last measurement, BMI, and family history of DM. BMI = body mass index; DM = diabetes mellitus; HCV = hepatitis C virus; HIV = human immunodeficiency virus; Pre-DM = pre-diabetes mellitus; PWH = persons with HIV; PWOH = persons without HIV.
Figure 1b.
Figure 1b.
Difference in the probability of transitioning from pre-DM to DM between PWH and PWOH at each year in time since the first visit with confirmed pre-DM. Estimates adjusted for age, number of previous transitions from pre-DM to DM, race/ethnicity, HCV infection as per last measurement, BMI, family history of DM, and waist-hip ratio. BMI = body mass index; DM = diabetes mellitus; HCV = hepatitis C virus; HIV = human immunodeficiency virus; Pre-DM = pre-diabetes mellitus; PWH = persons with HIV; PWOH = persons without HIV

Similar articles

Cited by

References

    1. Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS 2012; 26(3):303–314. - PubMed
    1. Erlandson KM, Kitch D, Tierney C, Sax PE, Daar ES, Melbourne KM, et al. Impact of randomized antiretroviral therapy initiation on glucose metabolism. AIDS 2014; 28(10):1451–1461. - PMC - PubMed
    1. Tebas P Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options. J Acquir Immune Defic Syndr 2008; 49 Suppl 2:S86–92. - PubMed
    1. Monroe AK, Glesby MJ, Brown TT. Diagnosing and managing diabetes in HIV-infected patients: current concepts. Clin Infect Dis 2015; 60(3):453–462. - PubMed
    1. Ghehi C, Gabillard D, Moh R, Badje A, Kouame GM, Oouttara E, et al. High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Cote d’Ivoire. PLoS One 2017; 12(6):e0177440. - PMC - PubMed

Publication types